TY  - JOUR
AU  - Kavanagh, Meaghan E
AU  - Chiavaroli, Laura
AU  - Quibrantar, Selina M
AU  - Viscardi, Gabrielle
AU  - Ramboanga, Kimberly
AU  - Amlin, Natalie
AU  - Paquette, Melanie
AU  - Sahye-Pudaruth, Sandhya
AU  - Patel, Darshna
AU  - Grant, Shannan M
AU  - Glenn, Andrea J
AU  - Ayoub-Charette, Sabrina
AU  - Zurbau, Andreea
AU  - Josse, Robert G
AU  - Malik, Vasanti S
AU  - Kendall, Cyril W C
AU  - Jenkins, David J A
AU  - Sievenpiper, John L
PY  - 2025
DA  - 2025/3/28
TI  - Acceptability of a Web-Based Health App (PortfolioDiet.app) to Translate a Nutrition Therapy for Cardiovascular Disease in High-Risk Adults: Mixed Methods Randomized Ancillary Pilot Study
JO  - JMIR Cardio
SP  - e58124
VL  - 9
KW  - diet
KW  - apps
KW  - dietary app
KW  - Portfolio Diet
KW  - dietary portfolio
KW  - cholesterol reduction
KW  - cardiovascular disease
KW  - eHealth
KW  - usability
KW  - acceptability
AB  - Background: The Portfolio Diet is a dietary pattern for cardiovascular disease (CVD) risk reduction with 5 key categories including nuts and seeds; plant protein from specific food sources; viscous fiber sources; plant sterols; and plant-derived monounsaturated fatty acid sources. To enhance implementation of the Portfolio Diet, we developed the PortfolioDiet.app, an automated, web-based, multicomponent, patient-facing health app that was developed with psychological theory. Objective: We aimed to evaluate the effect of the PortfolioDiet.app on dietary adherence and its acceptability among adults with a high risk of CVD over 12 weeks. Methods: Potential participants with evidence of atherosclerosis and a minimum of one additional CVD risk factor in an ongoing trial were invited to participate in a remote web-based ancillary study by email. Eligible participants were randomized in a 1:1 ratio using a concealed computer-generated allocation sequence to the PortfolioDiet.app group or a control group for 12 weeks. Adherence to the Portfolio Diet was assessed by weighed 7-day diet records at baseline and 12 weeks using the clinical Portfolio Diet Score, ranging from 0 to 25. Acceptability of the app was evaluated using a multifaceted approach, including usability through the System Usability Scale ranging from 0 to 100, with a score >70 being considered acceptable, and a qualitative analysis of open-ended questions using NVivo 12. Results: In total, 41 participants were invited from the main trial to join the ancillary study by email, of which 15 agreed, and 14 were randomized (8 in the intervention group and 6 in the control group) and completed the ancillary study. At baseline, adherence to the Portfolio Diet was high in both groups with a mean clinical Portfolio Diet Score of 13.2 (SD 3.7; 13.2/25, 53%) and 13.7 (SD 5.8; 13.7/25, 55%) in the app and control groups, respectively. After the 12 weeks, there was a tendency for a mean increase in adherence to the Portfolio Diet by 1.25 (SD 2.8; 1.25/25, 5%) and 0.19 (SD 4.4; 0.19/25, 0.8%) points in the app and control group, respectively, with no difference between groups (P=.62). Participants used the app on average for 18 (SD 14) days per month and rated the app as usable (System Usability Scale of mean 80.9, SD 17.3). Qualitative analyses identified 4 main themes (user engagement, usability, external factors, and added components), which complemented the quantitative data obtained. Conclusions: Although adherence was higher for the PortfolioDiet.app group, no difference in adherence was found between the groups in this small ancillary study. However, this study demonstrates that the PortfolioDiet.app is considered usable by high-risk adults and may reinforce dietitian advice to follow the Portfolio Diet when it is a part of a trial for CVD management. Trial Registration: ClinicalTrials.gov NCT02481466; https://clinicaltrials.gov/study/NCT02481466 
SN  - 2561-1011
UR  - https://cardio.jmir.org/2025/1/e58124
UR  - https://doi.org/10.2196/58124
DO  - 10.2196/58124
ID  - info:doi/10.2196/58124
ER  -